Anne-Laure Vitte

1.4k total citations
16 papers, 771 citations indexed

About

Anne-Laure Vitte is a scholar working on Molecular Biology, Virology and Genetics. According to data from OpenAlex, Anne-Laure Vitte has authored 16 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 3 papers in Virology and 3 papers in Genetics. Recurrent topics in Anne-Laure Vitte's work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and RNA modifications and cancer (3 papers). Anne-Laure Vitte is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers) and RNA modifications and cancer (3 papers). Anne-Laure Vitte collaborates with scholars based in France, United States and Iran. Anne-Laure Vitte's co-authors include Sophie Rousseaux, Saadi Khochbin, Sandrine Curtet, Jonathan Gaucher, Darren J. Hart, Carlo Petosa, Montserrat Soler‐López, Karin Sadoul, Jeanne Morinière and Ulrich Steuerwald and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Anne-Laure Vitte

15 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne-Laure Vitte France 10 679 125 105 78 69 16 771
Christophe Pivôt-Pajot France 7 521 0.8× 49 0.4× 210 2.0× 46 0.6× 169 2.4× 8 694
Takahiko Seki Japan 15 558 0.8× 83 0.7× 48 0.5× 50 0.6× 4 0.1× 27 670
Jill Horowitz United States 9 377 0.6× 61 0.5× 55 0.5× 21 0.3× 72 1.0× 9 527
Jan Taplick Austria 8 554 0.8× 34 0.3× 63 0.6× 55 0.7× 5 0.1× 8 621
Samantha Ciccone United States 13 493 0.7× 84 0.7× 106 1.0× 60 0.8× 4 0.1× 13 573
Jing Qi China 11 292 0.4× 88 0.7× 140 1.3× 222 2.8× 14 0.2× 25 602
Chioma J. Madubata United States 6 352 0.5× 34 0.3× 72 0.7× 20 0.3× 12 0.2× 7 434
Adrian T. Grzybowski United States 12 474 0.7× 23 0.2× 39 0.4× 29 0.4× 15 0.2× 13 535
Voahangy Randrianarison France 7 548 0.8× 24 0.2× 317 3.0× 33 0.4× 12 0.2× 9 663
Allen Sirotkin United States 9 531 0.8× 14 0.1× 119 1.1× 115 1.5× 52 0.8× 9 623

Countries citing papers authored by Anne-Laure Vitte

Since Specialization
Citations

This map shows the geographic impact of Anne-Laure Vitte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne-Laure Vitte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne-Laure Vitte more than expected).

Fields of papers citing papers by Anne-Laure Vitte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne-Laure Vitte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne-Laure Vitte. The network helps show where Anne-Laure Vitte may publish in the future.

Co-authorship network of co-authors of Anne-Laure Vitte

This figure shows the co-authorship network connecting the top 25 collaborators of Anne-Laure Vitte. A scholar is included among the top collaborators of Anne-Laure Vitte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne-Laure Vitte. Anne-Laure Vitte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Vitte, Anne-Laure, Florent Chuffart, Emmanuelle Jacquet, et al.. (2025). Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach. NAR Cancer. 7(2). zcaf020–zcaf020.
2.
Jacquet, Emmanuelle, Florent Chuffart, Anne-Laure Vitte, et al.. (2023). Aberrant activation of five embryonic stem cell-specific genes robustly predicts a high risk of relapse in breast cancers. BMC Genomics. 24(1). 463–463. 4 indexed citations
3.
Chabert, Clovis, Anne-Laure Vitte, Domenico Iuso, et al.. (2022). AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome. International Journal of Molecular Sciences. 23(3). 1911–1911. 11 indexed citations
4.
Vargas, Alexandra, Amir Amiri‐Yekta, Anne-Laure Vitte, et al.. (2022). Direct visualization of pre-protamine 2 detects protamine assembly failures and predicts ICSI success. Molecular Human Reproduction. 28(2). 7 indexed citations
5.
a-Flin, Ekaterina Bourov, Afsaneh Goudarzi, Tao Wang, et al.. (2021). The combined detection of Amphiregulin, Cyclin A1 and DDX20/Gemin3 expression predicts aggressive forms of oral squamous cell carcinoma. British Journal of Cancer. 125(8). 1122–1134. 17 indexed citations
6.
Buchou, Thierry, Minjia Tan, Sophie Barral, et al.. (2016). Purification and Analysis of Male Germ Cells from Adult Mouse Testis. Methods in molecular biology. 1510. 159–168. 6 indexed citations
7.
Wang, Jin, Jian‐Qing Mi, Alexandra Debernardi, et al.. (2015). A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia. Oncotarget. 6(18). 16527–16542. 28 indexed citations
8.
Vitte, Anne-Laure, Alexandra Debernardi, Sandrine Curtet, et al.. (2014). Receptor-Independent Ectopic Activity of Prolactin Predicts Aggressive Lung Tumors and Indicates HDACi-Based Therapeutic Strategies. Antioxidants and Redox Signaling. 23(1). 1–14. 13 indexed citations
9.
Gaucher, Jonathan, Fayçal Boussouar, Emilie Montellier, et al.. (2012). Bromodomain‐dependent stage‐specific male genome programming by Brdt. The EMBO Journal. 31(19). 3809–3820. 187 indexed citations
10.
Rousseaux, Sophie, Fayçal Boussouar, Jonathan Gaucher, et al.. (2011). Molecular models for post-meiotic male genome reprogramming. Systems Biology in Reproductive Medicine. 57(1-2). 50–53. 13 indexed citations
11.
Eymery, Angéline, Béatrice Horard, Geneviève Fourel, et al.. (2009). A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucleic Acids Research. 37(19). 6340–6354. 94 indexed citations
12.
Morinière, Jeanne, Sophie Rousseaux, Ulrich Steuerwald, et al.. (2009). Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature. 461(7264). 664–668. 345 indexed citations
13.
Rousseaux, Sophie, Jonathan Gaucher, Julien Thévenon, et al.. (2009). Spermiogenèse : l’acétylation des histones déclenche la reprogrammation du génome mâle. Gynécologie Obstétrique & Fertilité. 37(6). 519–522. 9 indexed citations
14.
Vitte, Anne-Laure & Pierre Jalinot. (2008). Intracellular delivery of peptides via association with ubiquitin or SUMO-1 coupled to protein transduction domains. BMC Biotechnology. 8(1). 24–24. 5 indexed citations
15.
Vitte, Anne-Laure, et al.. (2006). Modulation of HIV‐1 Rev protein abundance and activity by polyubiquitination with unconventional Lys‐33 branching. FEBS Letters. 580(26). 6155–6160. 7 indexed citations
16.
Dereuddre‐Bosquet, Nathalie, et al.. (2004). Inhibition of HIV-1 Replication by Cell-penetrating Peptides Binding Rev. Journal of Biological Chemistry. 279(10). 9208–9214. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026